Spots Global Cancer Trial Database for prostate cancer, bibw 2992 (afatinib) , her inhibitor
Every month we try and update this database with for prostate cancer, bibw 2992 (afatinib) , her inhibitor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| BIBW 2992 (Afatinib) for the Treatment of Patients With HER2-positive, Hormone-refractory Prostate Cancer | NCT01320280 | Refractory Canc... | BIBW 2992 (Afat... | 18 Years - | Universitätsklinikum Hamburg-Eppendorf |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
